tapepowered by dorch

INBX Inhibrx Biosciences, Inc. · NASDAQ · Biological Products, (No Diagnostic Substances)

What each lens says: insiders — insiders bought $5.5M and sold $0.3M in 30 days (14 buys, 5 sales) · funds — Viking Global cut or exited

no price series yet

What the readers say — 0 reads of posts over 50 upvotes, last 30 days

no reads yet — the model key is not set on the server

posts per day (height) and word-score mood (color), gated

Connected to INBX — asked of the layer, served live

funds.holdings
  • references ×1 13f:0001103804-26-000004:45720N103
  • references ×1 13f:0001103804-26-000006:45720N103
funds.securities
  • references ×1 INHIBRX BIOSCIENCES INC
insiders.trades
news.articles

open the relational graph ↗

History of INBX — the layer's log: every relationship that appeared, strengthened or faded

  • 2026-09-28 23:10 appeared references form4:0001366074-26-000004:3 insiders.trades · crossed the bar · ×1
  • 2026-09-28 23:10 appeared references form4:0001366074-26-000004:2 insiders.trades · crossed the bar · ×1
  • 2026-09-28 23:10 appeared references form4:0001366074-26-000004:1 insiders.trades · crossed the bar · ×1
  • 2026-09-28 23:10 appeared references form4:0001366074-26-000004:0 insiders.trades · crossed the bar · ×1
  • 2026-09-24 07:15 strengthened references news:8a943d2417485427 news.articles · ×4
  • 2026-09-24 07:15 strengthened references news:756e67bb0d41d6d2 news.articles · ×16
  • 2026-09-24 07:15 strengthened references news:a885dea2f82c4685 news.articles · ×16
  • 2026-09-24 07:15 strengthened references news:129a3c8eab2a6ffc news.articles · ×8
  • 2026-09-24 07:15 appeared references news:a1c6bc814ebe5451 news.articles · crossed the bar · ×1
  • 2026-09-24 07:15 strengthened references news:65e91063ffc358da news.articles · ×4
  • 2026-09-24 07:15 strengthened references news:9cecd9f19c08da4b news.articles · ×2
  • 2026-09-24 07:15 appeared references news:e1bd88fb29c19234 news.articles · crossed the bar · ×1
  • 2026-09-24 07:15 appeared references news:09797c7fc55d54e4 news.articles · crossed the bar · ×1
  • 2026-09-23 21:05 appeared references form4:0001366268-26-000011:0 insiders.trades · crossed the bar · ×1

The reads — each post's actual stance, by a language model

no reads yet for this ticker

Reddit posts — over 50 upvotes

post⬆flairword score
no gated posts yet

The comments — loudest in 30 days, over 10 upvotes

no loud comments naming this ticker yet

News

seenheadlinesource
2026-09-23T22:27Inhibrx Biosciences director Jon Kayyem buys $500,000 in common stock By Investing.comInvesting.com Nigeria
2026-09-23T20:59At $100 a share, a director's family trust bought 5,000 shares of Inhibrx Biosciences (INBX).Stock Titan
2026-09-21T23:51Inhibrx Biosciences stock gains on insider buying and trial progressAD HOC NEWS
2026-09-20T15:07Inhibrx Biosciences stock gains institutional support as Bank of America investsAD HOC NEWS
2026-09-18T22:17Inhibrx Biosciences Director Kristiina Vuori Receives Corrected Stock Option GrantKalkine Media
2026-09-18T22:17Inhibrx Biosciences Director Kimberly Manhard Revises Stock Option Grant FilingKalkine Media
2026-09-18T20:26Director at Inhibrx (NASDAQ: INBX) awarded 10,000 optionsStock Titan
2026-09-18T20:26Inhibrx (NASDAQ: INBX) director gets 10,000 options expiring 2036Stock Titan
2026-09-18T20:22Inhibrx (INBX) corrects director's 10,000-option grantStock Titan
2026-09-18T20:21Inhibrx (INBX) corrects 10,000-option grant to directorStock Titan
2026-09-17T22:52Inhibrx Biosciences director Jon Kayyem buys $500,000 in stock By Investing.comInvesting.com South Africa
2026-09-17T22:39Inhibrx Biosciences director Jon Kayyem buys $500,000 in stockInvesting.com
2026-09-17T22:28Inhibrx Biosciences director Jon Kayyem buys $500,000 in stock By Investing.comInvesting.com Canada
2026-09-17T22:16Inhibrx Biosciences director Jon Kayyem buys $500,000 in stock By Investing.comInvesting.com UK
2026-09-17T21:47Family trust of Inhibrx (INBX) director adds 5,000 shares at $100Stock Titan
2026-09-16T03:31Inhibrx director Kimberly Manhard sells $163,542 in company stock By Investing.comInvesting.com Australia
2026-09-15T21:53Director’s trust sells 1,500 Inhibrx (INBX) sharesStock Titan
2026-09-15T20:02Director’s trust at Inhibrx (NASDAQ: INBX) logs four 500-share stock salesStock Titan
2026-09-15T17:20How Inhibrx Biosciences Inc Com (INBX) Affects Rotational Strategy TimingStock Traders Daily
2026-09-14T07:00Inhibrx (NASDAQ: INBX) director's trust files to sell 500 sharesStock Titan

Who holds it — the big funds' 13F reports, each manager's newest quarter

managerpositionsharesmove vs prior quarteras of
Viking Global$106M1,123,929decreased2026-06-30

Insider trades — Form 4 open-market buys and sales

tradedfiledwhosidesharespricevalue
2026-09-282026-09-28Lappe Mark Chief Executive Officerbuy1,500$98.88$148,320
2026-09-282026-09-28Lappe Mark Chief Executive Officerbuy3,000$101.70$305,106
2026-09-252026-09-28Lappe Mark Chief Executive Officerbuy3,324$98.87$328,630
2026-09-252026-09-28Lappe Mark Chief Executive Officerbuy2,176$99.60$216,727
2026-09-232026-09-23Kayyem Jon Faiz directorbuy5,000$100.00$500,000
2026-09-162026-09-17Kayyem Jon Faiz directorbuy5,000$100.00$500,000
2026-09-152026-09-15MANHARD KIMBERLY directorsell500$105.05$52,525
2026-09-142026-09-15MANHARD KIMBERLY directorsell500$110.26$55,130
2026-09-112026-09-15MANHARD KIMBERLY directorsell500$111.78$55,888
2026-09-092026-09-10MANHARD KIMBERLY directorsell500$115.80$57,898
2026-09-082026-09-08Lappe Mark Chief Executive Officerbuy5,895$99.29$585,343
2026-09-082026-09-08Lappe Mark Chief Executive Officerbuy6,605$100.64$664,719
2026-09-082026-09-08Lappe Mark Chief Executive Officerbuy1,100$107.12$117,836
2026-09-082026-09-08Lappe Mark Chief Executive Officerbuy500$108.23$54,118
2026-09-082026-09-08Lappe Mark Chief Executive Officerbuy1,219$111.88$136,382
2026-09-082026-09-08Lappe Mark Chief Executive Officerbuy9,681$112.28$1,087,001
2026-09-082026-09-08FORSYTH DOUGLAS directorbuy2,500$114.65$286,617
2026-09-082026-09-08Kayyem Jon Faiz directorbuy5,000$113.52$567,580
2026-09-082026-09-10MANHARD KIMBERLY directorsell500$115.14$57,570

Congressional trades — House periodic transaction reports

tradedfiledmembertypeowneramount
no filings naming this ticker in the window